M&A Deal Summary |
|
|---|---|
| Date | 2023-04-04 |
| Target | Envalior |
| Sector | Chemicals |
| Buyer(s) |
Advent International
LANXESS |
| Deal Type | Joint Venture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1984 |
| PE ASSETS | 76.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 329 of 341 |
| Sector (Chemicals) | 11 of 11 |
| Type (Joint Venture) | 2 of 2 |
| Country (Germany) | 22 of 22 |
| Year (2023) | 2 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-03-07 |
Tag
Norwich, United Kingdom Tag is a provider of marketing and communications supply chain services. Tag helps organizations transform business processes, enhance customer conversations and realize the potential of their brands. Tag was founded in 1820 and is based in Norwich, United Kingdom. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-08 |
Simtra BioPharma Solutions
Deerfield, Illinois, United States Simtra BioPharma Solutions partners with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face. Simtra BioPharma Solutions is based in Deerfield, Illinois. |
Buy | $4.3B |
LANXESS is a specialty chemicals company. The company is currently represented at 52 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of plastics, rubber, intermediates, and specialty chemicals. LAXNESS was founded in 1863 and is based in Cologne, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 17 |
| Sector (Chemicals) | 16 of 16 |
| Type (Joint Venture) | 2 of 2 |
| Country (Germany) | 3 of 3 |
| Year (2023) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-31 |
DSM Engineering Materials
Heerlen, Netherlands DSM Engineering Materials provides high-performance and increasingly sustainable thermoplastics used in automotive, electrical & electronics, building & construction, medical, food packaging, and consumer goods (to name but a few). Its materials enable lighter, stronger, and more durable products - which in turn makes people’s lives safer, more convenient, and healthier – and all while helping to tackle carbon emissions. |
Buy | €3.7B |
